384 related articles for article (PubMed ID: 15824337)
21. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.
Harsh JR; Hayduk R; Rosenberg R; Wesnes KA; Walsh JK; Arora S; Niebler GE; Roth T
Curr Med Res Opin; 2006 Apr; 22(4):761-74. PubMed ID: 16684437
[TBL] [Abstract][Full Text] [Related]
22. P300 and treatment effect of modafinil on fatigue in multiple sclerosis.
Nagels G; D'hooghe MB; Vleugels L; Kos D; Despontin M; De Deyn PP
J Clin Neurosci; 2007 Jan; 14(1):33-40. PubMed ID: 17138067
[TBL] [Abstract][Full Text] [Related]
23. Association of a deficit of arousal with fatigue in multiple sclerosis: effect of modafinil.
Niepel G; Bibani RH; Vilisaar J; Langley RW; Bradshaw CM; Szabadi E; Constantinescu CS
Neuropharmacology; 2013 Jan; 64():380-8. PubMed ID: 22766394
[TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial.
Nourbakhsh B; Revirajan N; Morris B; Cordano C; Creasman J; Manguinao M; Krysko K; Rutatangwa A; Auvray C; Aljarallah S; Jin C; Mowry E; McCulloch C; Waubant E
Lancet Neurol; 2021 Jan; 20(1):38-48. PubMed ID: 33242419
[TBL] [Abstract][Full Text] [Related]
25. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.
Biederman J; Pliszka SR
J Pediatr; 2008 Mar; 152(3):394-9. PubMed ID: 18280848
[TBL] [Abstract][Full Text] [Related]
26. Modafinil improves information processing speed and increases energetic resources for orientation of attention in narcoleptics: double-blind, placebo-controlled ERP studies with low-resolution brain electromagnetic tomography (LORETA).
Saletu M; Anderer P; Saletu-Zyhlarz GM; Mandl M; Saletu B; Zeitlhofer J
Sleep Med; 2009 Sep; 10(8):850-8. PubMed ID: 19342295
[TBL] [Abstract][Full Text] [Related]
27. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
Black J; Pardi D; Hornfeldt CS; Inhaber N
Sleep Med; 2009 Sep; 10(8):829-35. PubMed ID: 19616998
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study.
Rammohan KW; Rosenberg JH; Lynn DJ; Blumenfeld AM; Pollak CP; Nagaraja HN
J Neurol Neurosurg Psychiatry; 2002 Feb; 72(2):179-83. PubMed ID: 11796766
[TBL] [Abstract][Full Text] [Related]
29. An open study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis.
Jones DE; Newton JL
Aliment Pharmacol Ther; 2007 Feb; 25(4):471-6. PubMed ID: 17270003
[TBL] [Abstract][Full Text] [Related]
30. Evaluating the effects of amantadin, modafinil and acetyl-L-carnitine on fatigue in multiple sclerosis--result of a pilot randomized, blind study.
Ledinek AH; Sajko MC; Rot U
Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S86-9. PubMed ID: 24321164
[TBL] [Abstract][Full Text] [Related]
31. Absence of mood switch with and tolerance to modafinil: a replication study from a large private practice.
Nasr S; Wendt B; Steiner K
J Affect Disord; 2006 Oct; 95(1-3):111-4. PubMed ID: 16737742
[TBL] [Abstract][Full Text] [Related]
32. Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study.
DeBattista C; Doghramji K; Menza MA; Rosenthal MH; Fieve RR;
J Clin Psychiatry; 2003 Sep; 64(9):1057-64. PubMed ID: 14628981
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of modafinil in the treatment of cancer-related fatigue.
Cooper MR; Bird HM; Steinberg M
Ann Pharmacother; 2009 Apr; 43(4):721-5. PubMed ID: 19318599
[TBL] [Abstract][Full Text] [Related]
34. Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial.
Spathis A; Fife K; Blackhall F; Dutton S; Bahadori R; Wharton R; O'Brien M; Stone P; Benepal T; Bates N; Wee B
J Clin Oncol; 2014 Jun; 32(18):1882-8. PubMed ID: 24778393
[TBL] [Abstract][Full Text] [Related]
35. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications.
Holman AJ; Myers RR
Arthritis Rheum; 2005 Aug; 52(8):2495-505. PubMed ID: 16052595
[TBL] [Abstract][Full Text] [Related]
36. Modafinil reduces fatigue in Charcot-Marie-Tooth disease type 1A: a case series.
Carter GT; Han JJ; Mayadev A; Weiss MD
Am J Hosp Palliat Care; 2006; 23(5):412-6. PubMed ID: 17060310
[TBL] [Abstract][Full Text] [Related]
37. Modafinil for atypical depression: effects of open-label and double-blind discontinuation treatment.
Vaishnavi S; Gadde K; Alamy S; Zhang W; Connor K; Davidson JR
J Clin Psychopharmacol; 2006 Aug; 26(4):373-8. PubMed ID: 16855454
[TBL] [Abstract][Full Text] [Related]
38. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial.
Bruera E; Valero V; Driver L; Shen L; Willey J; Zhang T; Palmer JL
J Clin Oncol; 2006 May; 24(13):2073-8. PubMed ID: 16648508
[TBL] [Abstract][Full Text] [Related]
39. A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder.
Kahbazi M; Ghoreishi A; Rahiminejad F; Mohammadi MR; Kamalipour A; Akhondzadeh S
Psychiatry Res; 2009 Aug; 168(3):234-7. PubMed ID: 19439364
[TBL] [Abstract][Full Text] [Related]
40. Modafinil in children and adolescents with attention-deficit/hyperactivity disorder: a preliminary 8-week, open-label study.
Boellner SW; Earl CQ; Arora S
Curr Med Res Opin; 2006 Dec; 22(12):2457-65. PubMed ID: 17257460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
